first-line lung cancer Archives -

Roche has scored another FDA approval for Tecentriq alongside chemotherapy for previously-untreated, non-squamous non-small cell lung cancer (NSCLC),

Roche steps up Merck challenge with first-line NSCLC approval in US

https://pharmaphorum.com/news/roche-continues-merck-challenge-with-first-line-nsclc-approval-in-us/

News/ Oncology

Roche’s Tecentriq combo extends life in advanced NSCLC

Linda Banks ASCO 2018, first-line lung cancer, lung cancer, Non-small cell lung cancer, NSCLC, Oncology, Roche 0 Comment

Roche has announced that its phase 3 IMpower130 study met its co-primary endpoints of overall survival and progression-free survival in non-small cell lung cancer (NSCLC).

Roche’s Tecentriq combo extends life in advanced NSCLC

https://pharmaphorum.com/news/roches-tecentriq-combo-advanced-nsclc/

ASCO 2018/ Oncology/ Views & Analysis/ Views and analysis

ASCO 2018 Preview – what to expect from this year’s conference

Richard Staines ASCO 2018, cancer, CAR T, Celgene, Eisai, first-line lung cancer, Immunotherapies, Keytruda, Loxo Oncology, Merck & Co, Novartis, Oncology 0 Comment

pharmaphorum will be presenting live online coverage of this year’s ASCO 2018 conference, the biggest event of the

ASCO 2018 Preview – what to expect from this year’s conference

https://pharmaphorum.com/views-and-analysis/asco-2018-preview-conference/

Trending

first-line lung cancer

Login